ArticleInternational journal of molecular sciences2022
DNA Methylation Signature for
Open access · goldAbstract read
In one paragraph
Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 16 citations in OpenAlex.
- Discovery of a DNA methylation episignature for Weiss-Kruszka syndrome.Human genetics · 2026Article
- METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury.Cell biology and toxicology · 2026Article
- Episignature-based modelled first-tier diagnostic approach in the Dutch Caribbean: advancing equal care through epigenetic classification.Frontiers in genetics · 2026Article
- Analysis Methods for Diagnosing Rare Neurodevelopmental Diseases with Episignatures: A Systematic Review of the Literature.Biomedicines · 2025Review
- De novo variants in RYBP are associated with a severe neurodevelopmental disorder and congenital anomalies.Genetics in medicine : official journal of the American College of Medical Genetics · 2025Article
- The neurodevelopmental regulatory role and clinical value of hsa-circ-CORO1C-hsa-miR-708-3p-JARID2 + LNPEP axis in early-onset schizophrenia.Schizophrenia (Heidelberg, Germany) · 2024Article
- Association of HHV‑6 reactivation and SLC6A3 (C>T, rs40184), BDNF (C>T, rs6265), and JARID2 (G>A, rs9383046) single nucleotide polymorphisms in depression.Biomedical reports · 2024Article
- The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes.Human genetics · 2024Article
- A Functional Single Nucleotide Polymorphism in the 3' Untranslated Region of the Porcine JARID2 Gene Is Associated with Aggressive Behavior of Weaned Pigs after Mixing.International journal of molecular sciences · 2023Article
- Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs).Human genetics · 2023Article
- Functional Insight into and Refinement of the Genomic Boundaries of theInternational journal of molecular sciences · 2023Article
- Episignature Mapping ofInternational journal of molecular sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 10 institutions in 6 countries.
Eline A VerberneDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0003-2327-1666
Liselot van der LaanDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-7800-8665
Sadegheh HaghshenasDepartment of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
Kathleen RooneyDepartment of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.ORCID 0000-0002-7871-8982
Michael A LevyVerspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Mariëlle AldersDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Saskia M MaasDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Sandra JansenDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Agne LiedenDepartment of Clinical Genetics, Karolinska University Hospital, 17176 Stockholm, Sweden.
Britt-Marie AnderlidDepartment of Clinical Genetics, Karolinska University Hospital, 17176 Stockholm, Sweden.
Louise Rafael-CroesDepartment of Pediatrics, Dr. Horacio E. Oduber Hospital, Dr. Horacio E. Oduber Boulevard 1, Oranjestad, Aruba.
Philippe M CampeauDepartment of Pediatrics, University of Montreal, Montreal, QC H4A 3J1, Canada.
Ayeshah ChaudhryDepartment of Laboratory Medicine and Genetics, Trillium Health Partners, Mississauga, ON L5B 1B8, Canada.
David A KoolenDepartment of Hum Genet, Radboud Institute for Molecular Life Sciences and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-2152-4626
Rolph PfundtDepartment of Hum Genet, Radboud Institute for Molecular Life Sciences and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Anna C E HurstDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-9765-9703
Frederic Tran-Mau-ThemUF6254 Innovation en Diagnostic Genomique des Maladies Rares, 21070 Dijon, France.
Ange-Line BruelUF6254 Innovation en Diagnostic Genomique des Maladies Rares, 21070 Dijon, France.
Laetitia LambertService de Génétique Clinique, CHRU Nancy, 54000 Nancy, France.
Bertrand IsidorService de génétique médicale, CHU de Nantes, 44000 Nantes, France.
Marcel M A M MannensDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Bekim SadikovicDepartment of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
Peter HennemanDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Mieke M van HaelstDepartment of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLWestern University · CAKarolinska University Hospital · SERadboud University Nijmegen · NLCentre Hospitalier Universitaire de Nantes · FRLondon Health Sciences Centre · CAUniversité de Montréal · CAUniversity of Alabama at Birmingham · USUniversity of Aruba · AWUniversity of Toronto · CA
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
DNA MethylationPolycomb Repressive Complex 2HumansNucleotide MotifsPhenotypeProtein Processing, Post-TranslationalSyndromeJARID2 protein, humanPolycomb Repressive Complex 2developmental disorderDNA methylationepigeneticsepisignatureJARID2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.